Don’t Make Verbal Approvals for Critical GMP Decisions
Remember: All critical decisions in GMP environments — including batch release, deviation closure, and change control — must be documented. Verbal approvals are non-compliant and untraceable.
Why This Matters in GMP
GMP regulations emphasize traceability and documentation to ensure product safety, consistency, and accountability. Verbal approvals bypass this principle, making it difficult to verify who made the decision, when, and why. This compromises data integrity and creates audit vulnerabilities. Examples include verbal release of a batch pending documentation or verbal closure of a deviation without formal QA assessment.
Such practices introduce uncontrolled risk, where important decisions are made without cross-functional verification, leaving no paper trail for review or inspection. They also erode quality culture and open the door for miscommunication or unauthorized actions.
Regulatory and Compliance Implications
21 CFR Part 211.192 requires that all deviations and critical quality decisions be documented and reviewed by the quality unit. EU GMP Chapter 1 mandates formal decision-making processes with recorded approvals. WHO GMP reinforces that quality-related decisions must be traceable and documented.
Auditors scrutinize documentation trails for critical events. If verbal approvals are found — especially without supporting emails, memos, or system entries
Implementation Best Practices
Establish SOPs that require all critical decisions to be documented, signed, and stored in appropriate systems (e.g., eQMS, CAPA logs, batch records). Use digital approval workflows with audit trails. Allow only authorized personnel to approve decisions, and restrict verbal instructions to emergencies with mandatory written follow-up within 24 hours.
Train all departments on the risks of undocumented decisions and empower QA to enforce written approval protocols. Audit decision records periodically and flag any undocumented decisions for CAPA initiation.
Regulatory References
– 21 CFR Part 211.192 – Documentation of quality decisions
– EU GMP Chapter 1 – Documented responsibility and traceability
– WHO TRS 986, Annex 2 – Quality oversight and decision documentation
– MHRA GxP Data Integrity Guidance – Approval traceability